Barbara Domayne-Hayman
Corporate Officer/Principal presso Autifony Therapeutics Ltd.
Profilo
Barbara Domayne-Hayman is currently the Chief Business Officer at Autifony Therapeutics Ltd.
She previously worked as the Chief Executive Officer at Stabilitech Ltd., Commercial Director at Arrow Therapeutics Ltd., Director at Puridify Ltd., and Senior Manager-Business Development at Celltech Group Plc.
She also worked as a Principal at Zeneca Agrochemicals.
Dr. Domayne-Hayman received her undergraduate and doctorate degrees from the University of Oxford.
Posizioni attive di Barbara Domayne-Hayman
Società | Posizione | Inizio |
---|---|---|
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Precedenti posizioni note di Barbara Domayne-Hayman
Società | Posizione | Fine |
---|---|---|
Puridify Ltd.
Puridify Ltd. Miscellaneous Commercial ServicesCommercial Services Puridify Ltd. develops bioprocessing technologies. It develops a platform purification technology that will improve processing opportunities and reduce costs. The company was founded by Oliver Hardick, Iwan Thomas Roberts and Thomas Edward Haywood in 2013 and is headquartered in Stevenage, the United Kingdom. | Direttore/Membro del Consiglio | 24/11/2017 |
Stabilitech Ltd.
Stabilitech Ltd. BiotechnologyHealth Technology Stabilitech Ltd. develops technologies for the stabilization of biological molecules, such as vaccines and bio-pharmaceuticals. | Amministratore Delegato | - |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Corporate Officer/Principal | - |
Zeneca Agrochemicals | Corporate Officer/Principal | - |
Arrow Therapeutics Ltd.
Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Formazione di Barbara Domayne-Hayman
University of Oxford | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 6 |
---|---|
Arrow Therapeutics Ltd.
Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
Zeneca Agrochemicals | |
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Health Technology |
Stabilitech Ltd.
Stabilitech Ltd. BiotechnologyHealth Technology Stabilitech Ltd. develops technologies for the stabilization of biological molecules, such as vaccines and bio-pharmaceuticals. | Health Technology |
Puridify Ltd.
Puridify Ltd. Miscellaneous Commercial ServicesCommercial Services Puridify Ltd. develops bioprocessing technologies. It develops a platform purification technology that will improve processing opportunities and reduce costs. The company was founded by Oliver Hardick, Iwan Thomas Roberts and Thomas Edward Haywood in 2013 and is headquartered in Stevenage, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Barbara Domayne-Hayman